547
Views
7
CrossRef citations to date
0
Altmetric
Poison Centre

Ergotism and factitious hypotension associated with interaction of ergotamine with CYP3A4 inhibitors

, &
Pages 674-677 | Received 04 Mar 2014, Accepted 04 Jun 2014, Published online: 30 Jun 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Michael E. Mullins. (2018) Ergot toxicity from high-dose dihydroergotamine for intractable migraine headache. Toxicology Communications 2:1, pages 3-5.
Read now

Articles from other publishers (6)

Tushar Joshi, Priyanka Sharma, Shalini Mathpal, Tanuja Joshi, Priyanka Maiti, Mahesha Nand, Veena Pande & Subhash Chandra. (2021) Computational investigation of drug bank compounds against 3C-like protease (3CLpro) of SARS-CoV-2 using deep learning and molecular dynamics simulation. Molecular Diversity 26:4, pages 2243-2256.
Crossref
Yulia Y. Orlova, Sandhya Mehla & Abigail L. Chua. (2022) Drug Safety in Episodic Migraine Management in Adults Part 1: Acute Treatments. Current Pain and Headache Reports 26:7, pages 481-492.
Crossref
Irina I. Belyaeva, Anna G. Subbotina, Ivan I. Eremenko, Vadim V. Tarasov, Vladimir N. Chubarev, Helgi B. Schiöth & Jessica Mwinyi. (2022) Pharmacogenetics in Primary Headache Disorders. Frontiers in Pharmacology 12.
Crossref
Fabio Andrés Torres, Luis Alonso González, Gloria María Vásquez, Yamile Calle, Felipe Álvarez, Lina León & Daniel Jaramillo. (2020) Ergotism, a relatively unknown mimic of vasculitis: A case report and review of literature. Revista Colombiana de Reumatología (English Edition) 27:4, pages 303-307.
Crossref
Fabio Andrés Torres, Luis Alonso González, Gloria María Vásquez, Yamile Calle, Felipe Álvarez, Lina León & Daniel Jaramillo. (2020) Ergotism, a relatively unknown mimic of vasculitis: A case report and review of literature. Revista Colombiana de Reumatología 27:4, pages 303-307.
Crossref
. (2014) Multiple drugs. Reactions Weekly 1517:1, pages 137-137.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.